Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

A randomized trial involving patients with acute coronary syndromes showed that prasugrel was superior to ticagrelor with regard to the incidence of death, myocardial infarction, or stroke within 1 year, with no increased risk of bleeding.

Saved in:

Bibliographic Details
Published in:	The New England journal of medicine Vol. 381; no. 16; pp. 1524 - 1534
Main Authors:	Schüpke, Stefanie, Neumann, Franz-Josef, Menichelli, Maurizio, Mayer, Katharina, Bernlochner, Isabell, Wöhrle, Jochen, Richardt, Gert, Liebetrau, Christoph, Witzenbichler, Bernhard, Antoniucci, David, Akin, Ibrahim, Bott-Flügel, Lorenz, Fischer, Marcus, Landmesser, Ulf, Katus, Hugo A, Sibbing, Dirk, Seyfarth, Melchior, Janisch, Marion, Boncompagni, Duino, Hilz, Raphaela, Rottbauer, Wolfgang, Okrojek, Rainer, Möllmann, Helge, Hochholzer, Willibald, Migliorini, Angela, Cassese, Salvatore, Mollo, Pasquale, Xhepa, Erion, Kufner, Sebastian, Strehle, Axel, Leggewie, Stefan, Allali, Abdelhakim, Ndrepepa, Gjin, Schühlen, Helmut, Angiolillo, Dominick J, Hamm, Christian W, Hapfelmeier, Alexander, Tölg, Ralph, Trenk, Dietmar, Schunkert, Heribert, Laugwitz, Karl-Ludwig, Kastrati, Adnan
Format:	Journal Article
Language:	English
Published:	United States Massachusetts Medical Society 17.10.2019
Subjects:	Acute Coronary Syndrome - drug therapy Acute Coronary Syndrome - mortality Acute Coronary Syndrome - therapy Acute coronary syndromes Aged Bleeding Cerebral infarction Clinical trials Coronary Thrombosis - epidemiology Death Drug dosages Female Heart attacks Hemorrhage - chemically induced Humans Implants Incidence Kaplan-Meier Estimate Male Medical imaging Middle Aged Myocardial infarction Myocardial Infarction - epidemiology Myocardial Infarction - prevention & control Percutaneous Coronary Intervention Platelet Aggregation Inhibitors - adverse effects Platelet Aggregation Inhibitors - therapeutic use Prasugrel Hydrochloride - adverse effects Prasugrel Hydrochloride - therapeutic use Purinergic P2Y Receptor Antagonists - adverse effects Purinergic P2Y Receptor Antagonists - therapeutic use Stents Stroke - epidemiology Stroke - prevention & control Thrombosis Ticagrelor - adverse effects Ticagrelor - therapeutic use Germany
ISSN:	0028-4793, 1533-4406, 1533-4406
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!